These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Measuring chemotherapy-induced nausea and emesis. Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D. Cancer; 2003 Aug 01; 98(3):645-55. PubMed ID: 12879484 [Abstract] [Full Text] [Related]
64. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish. Jensen K, Jensen AB, Grau C. Acta Oncol; 2006 Aug 01; 45(1):28-37. PubMed ID: 16464793 [Abstract] [Full Text] [Related]
65. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Pezzilli R, Morselli-Labate AM, Fantini L, Campana D, Corinaldesi R. Dig Liver Dis; 2007 Dec 01; 39(12):1077-86. PubMed ID: 17692582 [Abstract] [Full Text] [Related]
68. Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction. Winters ZE, Balta V, Thomson HJ, Brandberg Y, Oberguggenberger A, Sinove Y, Unukovych D, Nava M, Sandelin K, Johansson H, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Group, Dobbeleir J, Blondeel P, Bruno N, Catanuto G, Llewellyn-Bennett R. Br J Surg; 2014 Mar 01; 101(4):371-82. PubMed ID: 24474151 [Abstract] [Full Text] [Related]
70. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). Lam WW, Law CC, Fu YT, Wong KH, Chang VT, Fielding R. J Pain Symptom Manage; 2008 Dec 01; 36(6):584-95. PubMed ID: 18434076 [Abstract] [Full Text] [Related]
71. Preliminary psychometric validation of the Polish version of the EORTC head and neck module (QLQ-H&N35). Tomaszewska IM, Glowacki R, Paradowska D, Walocha E. Folia Med Cracov; 2013 Dec 01; 53(1):55-63. PubMed ID: 24858331 [Abstract] [Full Text] [Related]
72. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. J Clin Oncol; 2005 Aug 01; 23(22):4936-44. PubMed ID: 16051946 [Abstract] [Full Text] [Related]
73. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma. Chmielowska K, Tomaszewski KA, Pogrzebielski A, Brandberg Y, Romanowska-Dixon B. Eur J Cancer Care (Engl); 2013 Jan 01; 22(1):88-96. PubMed ID: 22966840 [Abstract] [Full Text] [Related]
74. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Arraras JI, Kuljanic-Vlasic K, Bjordal K, Yun YH, Efficace F, Holzner B, Mills J, Greimel E, Krauss O, Velikova G, EORTC Quality of Life Group. Psychooncology; 2007 Mar 01; 16(3):249-54. PubMed ID: 16858744 [Abstract] [Full Text] [Related]
76. Impaired quality of life in patients commencing radiotherapy for cancer. Janda M, Newman B, Obermair A, Woelfl H, Trimmel M, Schroeckmayr H, Widder J, Poetter R. Strahlenther Onkol; 2004 Feb 01; 180(2):78-83. PubMed ID: 14762659 [Abstract] [Full Text] [Related]
80. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14). Wrazen W, Golec EB, Tomaszewska IM, Walocha E, Dudkiewicz Z, Tomaszewski KA. Folia Med Cracov; 2014 Feb 01; 54(2):35-45. PubMed ID: 25648308 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]